NPPA issued the retail price of the Desvenlafaxine Succinate USP Eq. to Desvenlafaxine 100 mg (In Extended-Release Form) + Clonazepam IP 0.5 mg' for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer)

Jul 19, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 16, 2026, issued the retail price of the Desvenlafaxine Succinate USP Eq. to Desvenlafaxine 100 mg (In Extended-Release Form) + Clonazepam IP 0.5 mg' for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer).

The following have been stated:

• The retail price for the Each Uncoated Bilayered Tablet Contains: Desvenlafaxine Succinate USP Eq. to Desvenlafaxine 100 mg (In Extended-Release Form) + Clonazepam IP 0.5 mg' for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer) will be Rs. 25.83/-.

• Sum of MAT value considered for price calculation (in Lakhs) - 1,513.08 

• Sum of PTR per unit considered for price calculation - 155.90

[Notification No. 19(5258)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT